Crossover Feasibility Study of Portable AP Device With Zone-MPC and HMS and Adapted I:C and Basal Insulin

NCT01929798 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
36
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Sansum Diabetes Research Institute

Collaborators